Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Literature DB >> 15917574

Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Kris P Heilmann¹, Cassie L Rice, Ashley L Miller, Norma J Miller, Susan E Beekmann, Michael A Pfaller, Sandra S Richter, Gary V Doern.

Abstract

A total of 986 isolates of Haemophilus influenzae from patients with respiratory tract infections in 45 United States medical centers were characterized during the winter of 2002-2003. beta-Lactamase production was noted with 26.2% of isolates; 14.6% were resistant to trimethoprim-sulfamethoxazole. Resistance to other relevant antimicrobial agents was extremely uncommon. In comparison to the results of four previous national surveys conducted since 1994, the prevalence of beta-lactamase production with this pathogen appears to be decreasing.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2005 PMID： 15917574 PMCID： PMC1140551 DOI： 10.1128/AAC.49.6.2561-2564.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

23 in total

1. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

Authors: James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena A Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Journal: J Clin Microbiol Date: 2002-03 Impact factor: 5.948

2. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

Authors: Clyde Thornsberry; Daniel F Sahm; Laurie J Kelly; Ian A Critchley; Mark E Jones; Alan T Evangelista; James A Karlowsky
Journal: Clin Infect Dis Date: 2002-03-01 Impact factor: 9.079

3. Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

Authors: James A Karlowsky; Deborah C Draghi; Clyde Thornsberry; Mark E Jones; Ian A Critchley; Daniel F Sahm
Journal: Int J Antimicrob Agents Date: 2002-08 Impact factor: 5.283

4. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.

Authors: Mark E Jones; James A Karlowsky; Renée Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
Journal: Int J Antimicrob Agents Date: 2002-02 Impact factor: 5.283

5. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.

Authors: Daryl Hoban; David Felmingham
Journal: J Antimicrob Chemother Date: 2002-09 Impact factor: 5.790

6. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Authors: Michael R Jacobs; David Felmingham; Peter C Appelbaum; Reuben N Grüneberg
Journal: J Antimicrob Chemother Date: 2003-07-15 Impact factor: 5.790

7. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.

Authors: Daryl Hoban; Ken Waites; David Felmingham
Journal: Diagn Microbiol Infect Dis Date: 2003-04 Impact factor: 2.803

8. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program.

Authors: Douglas J Biedenbach; Ronald N Jones
Journal: Diagn Microbiol Infect Dis Date: 2003-05 Impact factor: 2.803

9. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997).

Authors: G V Doern; R N Jones; M A Pfaller; K Kugler
Journal: Antimicrob Agents Chemother Date: 1999-02 Impact factor: 5.191

10. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.

Authors: C Thornsberry; P T Ogilvie; H P Holley; D F Sahm
Journal: Antimicrob Agents Chemother Date: 1999-11 Impact factor: 5.191

25 in total

1. Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.

Authors: L Qin; H Watanabe; N Asoh; K Watanabe; K Oishi; T Mizota; T Nagatake
Journal: Epidemiol Infect Date: 2006-09-06 Impact factor: 2.451

2. Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.

Authors: H Dabernat; C Delmas
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-04-27 Impact factor: 3.267

3. Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzae.

Authors: Erik L Munson; Gary V Doern
Journal: J Clin Microbiol Date: 2007-10-17 Impact factor: 5.948

4. Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada.

Authors: Michelle L Sill; Raymond S W Tsang
Journal: Antimicrob Agents Chemother Date: 2008-01-28 Impact factor: 5.191

5. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).

Authors: Emilio Pérez-Trallero; Jose E Martín-Herrero; Ana Mazón; Celia García-Delafuente; Purificación Robles; Victor Iriarte; Rafael Dal-Ré; Juan García-de-Lomas
Journal: Antimicrob Agents Chemother Date: 2010-05-03 Impact factor: 5.191

Review 6. The role of vaccines in preventing bacterial antimicrobial resistance.

Authors: Kathrin U Jansen; Charles Knirsch; Annaliesa S Anderson
Journal: Nat Med Date: 2018-01-09 Impact factor: 53.440

7. Characteristics of Haemophilus influenzae invasive isolates from Portugal following routine childhood vaccination against H. influenzae serotype b (2002-2010).

Authors: M P Bajanca-Lavado; A S Simões; C R Betencourt; R Sá-Leão
Journal: Eur J Clin Microbiol Infect Dis Date: 2013-10-24 Impact factor: 3.267

8. Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use.

Authors: Margaret A Davis; Thomas E Besser; Lisa H Orfe; Katherine N K Baker; Amelia S Lanier; Shira L Broschat; Daniel New; Douglas R Call
Journal: Appl Environ Microbiol Date: 2011-03-18 Impact factor: 4.792

9. Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.

Authors: Michael E Pichichero; Gary V Doern; Joseph L Kuti; David P Nicolau
Journal: Paediatr Drugs Date: 2008 Impact factor: 3.022

10. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007.

Authors: Silvia García-Cobos; José Campos; Emilia Cercenado; Federico Román; Edurne Lázaro; María Pérez-Vázquez; Francisco de Abajo; Jesús Oteo
Journal: Antimicrob Agents Chemother Date: 2008-05-27 Impact factor: 5.191